Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # Compounded Peptides Explained: APIs, COAs, 503A vs 503B & How Pharmacies Should Source Safely RXQ_503Avs503B_Infographic.jpg The Sikiric Problem: One Lab, Thirty Years, Zero Trials That Matter FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of